MedPath

Centre for Addiction and Mental Health

Centre for Addiction and Mental Health logo
🇨🇦Canada
Ownership
-
Established
1998-01-01
Employees
-
Market Cap
-
Website
http://www.camh.ca/en/hospital/Pages/home.aspx

Clinical Trials

332

Active:12
Completed:205

Trial Phases

6 Phases

Early Phase 1:4
Phase 1:14
Phase 2:29
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (311 trials with phase data)• Click on a phase to view related trials

Not Applicable
237 (76.2%)
Phase 2
29 (9.3%)
Phase 4
26 (8.4%)
Phase 1
14 (4.5%)
Early Phase 1
4 (1.3%)
Phase 3
1 (0.3%)

Efficacy of an EMDR App for PTSD and SUD

Not Applicable
Not yet recruiting
Conditions
Posttraumatic Stress Disorder (PTSD)
Substance Use Disorders
First Posted Date
2025-08-28
Last Posted Date
2025-08-28
Lead Sponsor
Centre for Addiction and Mental Health
Target Recruit Count
24
Registration Number
NCT07146633

Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

Not Applicable
Not yet recruiting
Conditions
Brain Insulin Sensitivity
Healthy Controls
Cognition
Interventions
Drug: Placebo
Other: Saline
First Posted Date
2025-08-07
Last Posted Date
2025-08-07
Lead Sponsor
Centre for Addiction and Mental Health
Target Recruit Count
35
Registration Number
NCT07109245
Locations
🇨🇦

Centre for Addiction and Mental Health, Toronto, Ontario, Canada

THC Titration of High-Potency Cannabis Concentrates

Not Applicable
Not yet recruiting
Conditions
THC
Interventions
Drug: Cannabis (30% THC Concentrate)
Drug: Cannabis (60% THC Concentrate)
Drug: Cannabis (90% THC Concentrate)
First Posted Date
2025-08-06
Last Posted Date
2025-08-06
Lead Sponsor
Centre for Addiction and Mental Health
Target Recruit Count
48
Registration Number
NCT07105449
Locations
🇨🇦

Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Theta-Burst Stimulation to Treat Depression

Phase 1
Recruiting
Conditions
Major Depressive Disorder (MDD)
First Posted Date
2025-06-24
Last Posted Date
2025-06-24
Lead Sponsor
Centre for Addiction and Mental Health
Target Recruit Count
84
Registration Number
NCT07033780
Locations
🇨🇦

Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration

Not Applicable
Recruiting
Conditions
Pedophilia
Hebephilia
Child Sexual Abuse
Program Evaluation
Prevention Intervention
Paraphilias and Paraphilic Disorders
First Posted Date
2025-06-03
Last Posted Date
2025-06-12
Lead Sponsor
Centre for Addiction and Mental Health
Target Recruit Count
220
Registration Number
NCT07001735
Locations
🇨🇦

Centre for Addiction and Mental Health, Toronto, Ontario, Canada

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 66
  • Next

News

Viatris Launches First Clozapine Orally Disintegrating Tablet in Canada for Treatment-Resistant Schizophrenia

Viatris has launched Gen-Clozapine orally disintegrating tablets in Canada, marking the first availability of this formulation for treatment-resistant schizophrenia patients.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.